• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Patients sue Olympus over superbug infections

Patients sue Olympus over superbug infections

February 26, 2015 By MassDevice Contributors Network

Patients sue Olympus over fatal superbug infection

(Reuters) — Attorneys for 2 patients infected with a drug-resistant bacterial "superbug" during medical procedures in a Los Angeles hospital, 1 of whom died, have sued the maker of the devices used in their care.

Aaron Young, an 18-year-old high school student who remains under monitoring at a hospital fighting the severe infection, and the family of Antonia Cerda sued Olympus (PINK:OCPNY), which manufactured the specialized scopes used during the outbreak at the UCLA Ronald Reagan Medical Center.

The suit alleged that the company’s reusable scope, also known as a duodenoscope, was unsafe because the cleaning protocols for the complex device were not updated following a recent redesign.

"Defendants continued to manufacture, sell, distribute, promote and supply the Q180V Scope as to maximize sales and profits at the expense of the health and safety of the public," according to the lawsuit.

Representatives for Olympus did not immediately return requests for comment on the lawsuits.

Both suits seek unspecified damages alleging fraud and negligence on the part of Olympus, and Cerda’s also included injury and wrongful death claims.

The plaintiffs allege that medical staff followed the company’s cleaning guidelines before using the devices, but plaintiffs’ attorney Pete Kaufman said UCLA and the University of California regents could be added as defendants after further investigation. Kaufman also said more patients would likely join the suit.

Cerda, whose case was filed yesterday, was exposed to 1 of the contaminated scopes as she underwent several procedures last October.

Young, who filed suit Feb. 23, went to the medical center in mid-2014 for a pancreatic ailment then became ill and was hospitalized a short time later, said Kevin Boyle, an attorney on his legal team. By November, he had been diagnosed with carbapenem-resistant enterobacteria, or CRE, the attorney said.

Seven patients were infected with CRE during endoscopies at the large Los Angeles teaching hospital between Oct. 3 and Jan. 28, and 2 died. Officials warned that as many as 179 people may have been exposed to the so-called superbug.

Officials have said there is no broader threat to public health, and that the hospital has called and sent letters to at-risk former patients.

All 5 of the confirmed infected patients who remain alive are under treatment, UCLA spokesman Enrique Rivero said yesterday.

The scopes, which are threaded through the mouth, throat and stomach and used in a variety of gastrointestinal procedures, can be difficult to disinfect properly, even when instructions provided by the manufacturers are followed, the FDA has said.

The federal safety watchdog has known since 2009 about the potential for the devices to transmit lethal infections, but hasn’t recommended any new safety requirements, a lapse that hospital-acquired infection experts say threatens patient safety.

Filed Under: Food & Drug Administration (FDA), Hospital Care, Legal News, News Well Tagged With: Olympus, University of California

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy